Skip to Main content Skip to Navigation
Journal articles

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Abstract : No abstract available
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03261177
Contributor : Laboratoire Carmen Connect in order to contact the contributor
Submitted on : Tuesday, June 15, 2021 - 2:57:16 PM
Last modification on : Sunday, November 14, 2021 - 6:00:07 PM
Long-term archiving on: : Thursday, September 16, 2021 - 6:50:52 PM

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

P. Sarafidis, C. J. Ferro, E. Morales, A. Ortiz, J. Malyszko, et al.. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, 35 (10), pp.1825. ⟨10.1093/ndt/gfz137⟩. ⟨inserm-03261177⟩

Share

Metrics

Record views

38

Files downloads

158